Prostate Cancer Market by Diagnostic Techniques (Digital Rectal Exam (DRE) and Prostate Specific Antigen Test (PSA)), by Surgery (Radical Prostatectomy, Orchidectomy and Trans Urethral Resection (TUR)), by Radiation Therapy (External Beam Radiation Therapy (3D Conformal Radiation Therapy, Intensity Modulated Radiation Therapy, Stereotactic Body Radiation Therapy and Proton Beam Radiation Therapy) and Brachytherapy (Permanent Brachytherapy and Temporary Brachytherapy)), by Chemotherapy (Docetaxel, Etoposide, Vinblastine, Carboplatin and Vinorelbine), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Prostate Cancer Market by Diagnostic Techniques (Digital Rectal Exam (DRE) and Prostate Specific Antigen Test (PSA)), by Surgery (Radical Prostatectomy, Orchidectomy and Trans Urethral Resection (TUR)), by Radiation Therapy (External Beam Radiation Therapy (3D Conformal Radiation Therapy, Intensity Modulated Radiation Therapy, Stereotactic Body Radiation Therapy and Proton Beam Radiation Therapy) and Brachytherapy (Permanent Brachytherapy and Temporary Brachytherapy)), by Chemotherapy (Docetaxel, Etoposide, Vinblastine, Carboplatin and Vinorelbine), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1616 | Pages: 179 | November 2016 | Region: Global


The Global Prostate Cancer Market was worth $48 billion in 2016 and estimated to be growing at a CAGR of 9.5%, to reach $75.56 billion by 2021. The prostate cancer market has a high demand for novel drugs that concentrate on unmet needs such as improved survival time, less toxicity, better progression free survival, improved effectiveness, and lesser cost.

Prostate cancer is a progression of cancer in the prostate, a gland present in the male reproductive system. The cancer cells might reach to the other parts of the body, viz. the bones and lymph nodes from the prostate. In the later stages of cancer it can cause difficulty in urination, blood in the urine, etc. Prostate cancer is most of the times diagnosed by biopsy.

These factors such as growing number of novel drugs expected to get launched in short-term future and rising old age male population are driving the growth of the market. Altering lifestyle, technological advancements in researching for new techniques to fight prostate cancer, increase in the funding in both public and private sector in the field of drug advancement are some of the key reasons driving the growth of the market. High cost of treatment is restraining the growth of the market.

The global Prostate Cancer market is segmented on the basis of diagnostic techniques into Digital Rectal Exam (DRE) and Prostate Specific Antigen Test (PSA). Based on surgery the market is segregated into Radical Prostatectomy, Orchidectomy and Trans Urethral Resection (TUR). By radiation therapy, the market is bifurcated into External Beam Radiation Therapy and Brachytherapy. External bean radiation therapy segment is further divided among 3D Conformal Radiation Therapy, Intensity Modulated Radiation Therapy, Stereotactic Body Radiation Therapy and Proton Beam Radiation Therapy. Brachytherapy segment is sub segmented into Permanent Brachytherapy and Temporary Brachytherapy. On the basis of chemotherapy, segments are Docetaxel, Etoposide, Vinblastine, Carboplatin and Vinorelbine.

Based on geography the market is analysed under various regions namely, North America, Latin America, Europe, Asia-Pacific and Middle-East & Africa. North America region holds the largest share in the global prostate cancer market. However, Asia-Pacific and Latin America region are estimated to record the highest CAGR during the forecast period.

Major companies include Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer, Johnson & Johnson, Abbott Laboratories, and Genentech etc. The market registered substantial growth in the recent years, due to the various strategies such as opting for agreements and collaborations, adopted by leading market players.

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 Epidemology             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 Diagnostic Techniques           

                                5.1.1 Introduction

                                5.1.2 Digital Rectal Exam (DRE)

                                5.1.3 Prostate Specific Antigen Test (PSA)

                                5.1.4 Y-o-Y Growth Analysis, By Product

                                5.1.5 Market Attractiveness Analysis, By Product

                                5.1.6 Market Share Analysis, By Product

                5.2 Surgery        

                                5.2.1 Introduction

                                5.2.2 Radical Prostatectomy

                                5.2.3 Orchidectomy

                                5.2.4 Trans Urethral Resection (TUR)

                                5.2.5 Y-o-Y Growth Analysis, By Type

                                5.2.6 Market Attractiveness Analysis, By Type

                                5.2.7 Market Share Analysis, By Type

                5.3 Radiation Therapy   

                                5.3.1 Introduction

                                5.3.2 External Beam Radiation Therapy

                                5.3.3 Brachytherapy

                                5.3.4 Y-o-Y Growth Analysis, By Application

                                5.3.5 Market Attractiveness Analysis, By Application

                                5.3.6 Market Share Analysis, By Application

                5.4 Chemotherapy         

                                5.4.1 Introduction

                                5.4.2 Docetaxel

                                5.4.3 Etoposide

                                5.4.4 Vinblastine

                                5.4.5 Carboplatin

                                5.4.6 Vinorelbine

                                5.4.7 Y-o-Y Growth Analysis, By Disease Indications

                                5.4.8 Market Attractiveness Analysis, By Disease Indications

                                5.4.9 Market Share Analysis, By Disease Indications

6. Geographical Analysis                              

                6.1 Introduction              

                                6.1.1 Regional Trends

                                6.1.2 Impact Analysis

                                6.1.3 Y-o-Y Growth Analysis

                                6.1.4 Market Attractiveness Analysis

                                6.1.5 Market Share Analysis               

                6.2 North America          

                                6.1.1 Introduction

                                6.1.2 United States

                                6.1.3 Canada 

                6.3 Europe         

                                6.2.1 Introduction

                                6.2.2 U.K

                                6.2.3 Spain

                                6.2.4 Germany

                                6.2.5 Italy 

                                6.2.6 France

                6.4 Asia-Pacific 

                                6.3.1 Introduction

                                6.3.2 China 

                                6.3.3 India 

                                6.3.4 Japan 

                                6.3.5 Australia

                                6.3.6 South Korea

                6.5 Latin America            

                                6.4.1 Introduction

                                6.4.2 Brazil

                                6.4.3 Argentina

                                6.4.4 Mexico

                                6.4.5 Rest of Latin America

                6.6 Middle East & Africa

                                6.5.1 Introduction

                                6.5.2 Middle-East

                                6.5.3 Africa

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Sanofi S.A    

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Financial analysis

                                8.1.4 Recent Developments

                                8.1.5 SWOT analysis

                                8.1.6 Analyst View

                8.2 GlaxoSmithKline      

                8.3 AstraZeneca

                8.4 AbbVie         

                8.5 Varian Medical Systems        

                8.6 Elekta           

                8.7 Theragenics

                8.8 Pfizer            

                8.9 Novartis       

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Market Outlook and Investment Opportunities                           

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Prostate Cancer Market By Region, From 2016-2021 ( USD Billion )
  2. Global Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  3. Global Digital Rectal Exam (DRE) Market By Region, From 2016-2021 ( USD Billion )
  4. Global Prostate Specific Antigen Test (PSA) Market By Region, From 2016-2021 ( USD Billion )
  5. Global Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  6. Global Radical Prostatectomy Market By Region, From 2016-2021 ( USD Billion )
  7. Global Orchidectomy Market By Region, From 2016-2021 ( USD Billion )
  8. Global Trans Urethral Resection (TUR) Market By Region, From 2016-2021 ( USD Billion )
  9. Global Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  10. Global External Beam Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  11. Global Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  12. Global Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  13. Global Docetaxel Market By Region, From 2016-2021 ( USD Billion )
  14. Global Etoposide Market By Region, From 2016-2021 ( USD Billion )
  15. Global Vinblastine Market By Region, From 2016-2021 ( USD Billion )
  16. Global Carboplatin Market By Region, From 2016-2021 ( USD Billion )
  17. Global Vinorelbine Market By Region, From 2016-2021 ( USD Billion )
  18. Global Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  19. Global 3D Conformal Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  20. Global Intensity Modulated Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  21. Global Stereotactic Body Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  22. Global Proton Beam Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  23. Global Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  24. Global Permanent Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  25. Global Temporary Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  26. North America Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  27. North America Digital Rectal Exam (DRE) Market By Region, From 2016-2021 ( USD Billion )
  28. North America Prostate Specific Antigen Test (PSA) Market By Region, From 2016-2021 ( USD Billion )
  29. North America Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  30. North America Radical Prostatectomy Market By Region, From 2016-2021 ( USD Billion )
  31. North America Orchidectomy Market By Region, From 2016-2021 ( USD Billion )
  32. North America Trans Urethral Resection (TUR) Market By Region, From 2016-2021 ( USD Billion )
  33. North America Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  34. North America External Beam Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  35. North America Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  36. North America Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  37. North America Docetaxel Market By Region, From 2016-2021 ( USD Billion )
  38. North America Etoposide Market By Region, From 2016-2021 ( USD Billion )
  39. North America Vinblastine Market By Region, From 2016-2021 ( USD Billion )
  40. North America Carboplatin Market By Region, From 2016-2021 ( USD Billion )
  41. North America Vinorelbine Market By Region, From 2016-2021 ( USD Billion )
  42. United States Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  43. United States Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  44. United States Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  45. United States Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  46. Canada Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  47. Canada Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  48. Canada Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  49. Canada Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  50. North America Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  51. North America 3D Conformal Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  52. North America Intensity Modulated Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  53. North America Stereotactic Body Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  54. North America Proton Beam Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  55. United States Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  56. Canada Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  57. North America Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  58. North America Permanent Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  59. North America Temporary Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  60. United States Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  61. Canada Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  62. Europe Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  63. Europe Digital Rectal Exam (DRE) Market By Region, From 2016-2021 ( USD Billion )
  64. Europe Prostate Specific Antigen Test (PSA) Market By Region, From 2016-2021 ( USD Billion )
  65. Europe Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  66. Europe Radical Prostatectomy Market By Region, From 2016-2021 ( USD Billion )
  67. Europe Orchidectomy Market By Region, From 2016-2021 ( USD Billion )
  68. Europe Trans Urethral Resection (TUR) Market By Region, From 2016-2021 ( USD Billion )
  69. Europe Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  70. Europe External Beam Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  71. Europe Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  72. Europe Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  73. Europe Docetaxel Market By Region, From 2016-2021 ( USD Billion )
  74. Europe Etoposide Market By Region, From 2016-2021 ( USD Billion )
  75. Europe Vinblastine Market By Region, From 2016-2021 ( USD Billion )
  76. Europe Carboplatin Market By Region, From 2016-2021 ( USD Billion )
  77. Europe Vinorelbine Market By Region, From 2016-2021 ( USD Billion )
  78. U.K. Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  79. U.K. Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  80. U.K. Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  81. U.K. Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  82. Germany Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  83. Germany Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  84. Germany Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  85. Germany Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  86. France Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  87. France Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  88. France Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  89. France Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  90. Italy Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  91. Italy Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  92. Italy Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  93. Italy Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  94. Spain Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  95. Spain Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  96. Spain Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  97. Spain Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  98. Europe Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  99. Europe 3D Conformal Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  100. Europe Intensity Modulated Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  101. Europe Stereotactic Body Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  102. Europe Proton Beam Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  103. U.K. Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  104. Germany Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  105. France Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  106. Italy Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  107. Spain Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  108. Europe Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  109. Europe Permanent Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  110. Europe Temporary Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  111. U.K. Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  112. Germany Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  113. France Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  114. Italy Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  115. Spain Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  116. Asia-Pacific Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  117. Asia-Pacific Digital Rectal Exam (DRE) Market By Region, From 2016-2021 ( USD Billion )
  118. Asia-Pacific Prostate Specific Antigen Test (PSA) Market By Region, From 2016-2021 ( USD Billion )
  119. Asia-Pacific Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  120. Asia-Pacific Radical Prostatectomy Market By Region, From 2016-2021 ( USD Billion )
  121. Asia-Pacific Orchidectomy Market By Region, From 2016-2021 ( USD Billion )
  122. Asia-Pacific Trans Urethral Resection (TUR) Market By Region, From 2016-2021 ( USD Billion )
  123. Asia-Pacific Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  124. Asia-Pacific External Beam Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  125. Asia-Pacific Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  126. Asia-Pacific Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  127. Asia-Pacific Docetaxel Market By Region, From 2016-2021 ( USD Billion )
  128. Asia-Pacific Etoposide Market By Region, From 2016-2021 ( USD Billion )
  129. Asia-Pacific Vinblastine Market By Region, From 2016-2021 ( USD Billion )
  130. Asia-Pacific Carboplatin Market By Region, From 2016-2021 ( USD Billion )
  131. Asia-Pacific Vinorelbine Market By Region, From 2016-2021 ( USD Billion )
  132. Japan Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  133. Japan Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  134. Japan Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  135. Japan Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  136. China Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  137. China Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  138. China Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  139. China Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  140. India Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  141. India Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  142. India Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  143. India Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  144. Australia Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  145. Australia Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  146. Australia Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  147. Australia Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  148. South Korea Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  149. South Korea Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  150. South Korea Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  151. South Korea Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  152. Asia-Pacific Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  153. Asia-Pacific 3D Conformal Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  154. Asia-Pacific Intensity Modulated Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  155. Asia-Pacific Stereotactic Body Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  156. Asia-Pacific Proton Beam Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  157. Japan Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  158. China Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  159. India Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  160. Australia Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  161. Asia-Pacific Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  162. Asia-Pacific Permanent Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  163. Asia-Pacific Temporary Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  164. Japan Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  165. China Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  166. India Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  167. Australia Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  168. Latin America Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  169. Latin America Digital Rectal Exam (DRE) Market By Region, From 2016-2021 ( USD Billion )
  170. Latin America Prostate Specific Antigen Test (PSA) Market By Region, From 2016-2021 ( USD Billion )
  171. Latin America Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  172. Latin America Radical Prostatectomy Market By Region, From 2016-2021 ( USD Billion )
  173. Latin America Orchidectomy Market By Region, From 2016-2021 ( USD Billion )
  174. Latin America Trans Urethral Resection (TUR) Market By Region, From 2016-2021 ( USD Billion )
  175. Latin America Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  176. Latin America External Beam Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  177. Latin America Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  178. Latin America Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  179. Latin America Docetaxel Market By Region, From 2016-2021 ( USD Billion )
  180. Latin America Etoposide Market By Region, From 2016-2021 ( USD Billion )
  181. Latin America Vinblastine Market By Region, From 2016-2021 ( USD Billion )
  182. Latin America Carboplatin Market By Region, From 2016-2021 ( USD Billion )
  183. Latin America Vinorelbine Market By Region, From 2016-2021 ( USD Billion )
  184. Brazil Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  185. Brazil Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  186. Brazil Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  187. Brazil Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  188. Argentina Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  189. Argentina Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  190. Argentina Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  191. Argentina Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  192. Mexico Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  193. Mexico Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  194. Mexico Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  195. Mexico Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  196. Rest of Latin America Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  197. Rest of Latin America Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  198. Rest of Latin America Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  199. Rest of Latin America Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  200. Latin America Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  201. Latin America 3D Conformal Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  202. Latin America Intensity Modulated Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  203. Latin America Stereotactic Body Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  204. Latin America Proton Beam Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  205. Brazil Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  206. Argentina Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  207. Mexico Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  208. Latin America Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  209. Latin America Permanent Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  210. Latin America Temporary Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  211. Brazil Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  212. Argentina Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  213. Mexico Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  214. Middle East & Africa Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  215. Middle East & Africa Digital Rectal Exam (DRE) Market By Region, From 2016-2021 ( USD Billion )
  216. Middle East & Africa Prostate Specific Antigen Test (PSA) Market By Region, From 2016-2021 ( USD Billion )
  217. Middle East & Africa Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  218. Middle East & Africa Radical Prostatectomy Market By Region, From 2016-2021 ( USD Billion )
  219. Middle East & Africa Orchidectomy Market By Region, From 2016-2021 ( USD Billion )
  220. Middle East & Africa Trans Urethral Resection (TUR) Market By Region, From 2016-2021 ( USD Billion )
  221. Middle East & Africa Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  222. Middle East & Africa External Beam Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  223. Middle East & Africa Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  224. Middle East & Africa Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  225. Middle East & Africa Docetaxel Market By Region, From 2016-2021 ( USD Billion )
  226. Middle East & Africa Etoposide Market By Region, From 2016-2021 ( USD Billion )
  227. Middle East & Africa Vinblastine Market By Region, From 2016-2021 ( USD Billion )
  228. Middle East & Africa Carboplatin Market By Region, From 2016-2021 ( USD Billion )
  229. Middle East & Africa Vinorelbine Market By Region, From 2016-2021 ( USD Billion )
  230. Middle East Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  231. Middle East Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  232. Middle East Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  233. Middle East Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  234. Africa Prostate Cancer Market By Diagnostic Techniques , From 2016-2021 ( USD Billion )
  235. Africa Prostate Cancer Market By Surgery, From 2016-2021 ( USD Billion )
  236. Africa Prostate Cancer Market By Radiation Therapy , From 2016-2021 ( USD Billion )
  237. Africa Prostate Cancer Market By Chemotherapy , From 2016-2021 ( USD Billion )
  238. Middle East & Africa Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  239. Middle East & Africa 3D Conformal Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  240. Middle East & Africa Intensity Modulated Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  241. Middle East & Africa Stereotactic Body Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  242. Middle East & Africa Proton Beam Radiation Therapy Market By Region, From 2016-2021 ( USD Billion )
  243. Middle East Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  244. Africa Prostate Cancer Market By External Beam Radiation Therapy , From 2016-2021 ( USD Billion )
  245. Middle East & Africa Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  246. Middle East & Africa Permanent Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  247. Middle East & Africa Temporary Brachytherapy Market By Region, From 2016-2021 ( USD Billion )
  248. Middle East Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
  249. Africa Prostate Cancer Market By Brachytherapy, From 2016-2021 ( USD Billion )
Middle East and Africa Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Servic...
Latin America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Asia-Pacific Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskil...
Europe Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskilled Ca...
North America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Home Healthcare Market by Product (Mobility Care Products ,Screening, & Monitoring Products, Testing, Therapeutic Products) by Service (Infusion Therapy Services, Rehabilitation Therapy Services, Unskilled Care Serv...
Middle East and Africa Thyroid cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Ret...
Latin America Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharm...
Asia Pacific Thyroid cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharma...
Europe Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by end user (Hospital, Oncology centers, Hospital Pharmacies and Retail Pharmacies....
North America Market Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user (Hospital, Oncology centers, Hospital Pharmacies and Reta...
Thyroid Cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharmacies.) and by...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.